Archive · 14 Jun 2025
Sun Pharma Announces Leadership Changes, Ganorkar to MD
Sun Pharma, a major pharmaceutical company, is making changes to its leadership.
Kirti Ganorkar will become the new boss (Managing Director) starting September 1, 2025.
The current boss, Dilip Shanghvi, will become Executive Chairman.
Also, there is a change in North America: Richard Ascroft is the new CEO.
The company wants to keep growing and adapt to the changing market.
Kirti Ganorkar will become Managing Director of Sun Pharmaceutical Industries on September 1, 2025.
Dilip Shanghvi will step down as Managing Director and become Executive Chairman.
Richard Ascroft has been appointed as CEO of Sun Pharma's North America business.
Abhay Gandhi is resigning from his role as CEO of Sun Pharma's North America business after three decades.
Ganorkar joined Sun Pharma in 2019 and currently leads the India business.
- Who
- Kirti Ganorkar, Dilip Shanghvi, Richard Ascroft, and Abhay Gandhi.
- What
- Kirti Ganorkar will become Managing Director.
- When
- Effective September 1, 2025.
- Where
- Sun Pharmaceutical Industries.
- Why
- To manage succession planning and strengthen global market operations.
- New MD
- Kirti Ganorkar
- Effective Date
- September 1, 2025
- Shanghvi's New Role
- Executive Chairman
- North America CEO
- Richard Ascroft
- Previous North America CEO
- Abhay Gandhi
- Ganorkar's Joining Year
- 2019
Sources
Succession planning at Sun Pharma: Kirti Ganorkar appointed as Managing Director
Sun Pharma names Kirti Ganorkar as new managing director, Dilip Shanghvi to continue as chairman
Who Is Kirti Ganorkar, the New Managing Director (Designate) of Sun Pharma?
Who Is Kirti Ganorkar? From Engineer To MD, The Veteran Insider Set To Lead Sun Pharma
Who Is Kirti Ganorkar? Meet The Successor To Sun Pharma Chief Dilip Shanghvi
